Aigen Investment Management, LP

Position in SNY — Sanofi

CIK 1741224 NEW YORK, NY

Position in SNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$612,554

+$196,283 QoQ

Shares Held

14,359

+67.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#307

of 712 holders

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $6,988,444 across 5 Drug Manufacturers - General names. SNY ranks #4 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	29,983	$3,788,052
2	LLY	ELI LILLY & Co	1,102	$1,321,771
3	JNJ	Johnson & Johnson	3,601	$914,545
4	SNY	Sanofi This page	14,359	$612,554
5	NVS	Novartis AG	2,243	$351,522

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$612,554	14,359	+67.2%	Shares	Sole	2026-08-14
2025-12-31	$416,271	8,590	-36.4%	Shares	Sole	2026-02-13
2025-09-30	$637,294	13,502	+129.2%	Shares	Sole	2025-11-14
2024-12-31	$284,171	5,892	-90.9%	Shares	Sole	2025-02-06
2022-09-30	$2,462,669	64,773	+542.0%	Shares	Sole	2022-11-09
2021-12-31	$505,509	10,090	+91627.3%	Shares	Sole	2022-02-11
2020-03-31	$480	11	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.